Investing.com - Financial Markets Worldwide
💙 🔷 Not impressed by Big Tech in Q3? Explore these Blue Chip Bargains insteadExplore for free

Canadian vitamin maker Jamieson up for sale by CCMP -sources

Published 2016-05-02, 07:40 p/m
© Reuters. Canadian vitamin maker Jamieson up for sale by CCMP -sources

By Lauren Hirsch, Denny Thomas and John Tilak
NEW YORK/HONG KONG/TORONTO, May 2 (Reuters) - U.S. private
equity firm CCMP Capital Advisors is trying to sell Jamieson
Laboratories about two years after buying the Canadian vitamin
maker, according to three sources familiar with the situation.
CCMP, which has hired investment banks Houlihan Lokey and
Nomura to facilitate the sale, has received some approaches from
potential buyers, said the sources, who spoke on condition of
anonymity as the matter was not public.
Huge interest in health and wellness in Asia has fueled
interest in the vitamins market, and Chinese players are looking
to expand beyond their borders.
One source said Jamieson could go for a multiple of 12 to 14
times EBITDA, which would be roughly $600 million to $700
million. Jamieson was sold in 2014 for about $300 million, which
was a multiple of 10 times adjusted EBITDA, the source said.
Houlihan Lokey, which advised Jamieson on the previous sale
to CCMP, and Nomura did not immediately respond to requests for
comment. CCMP declined comment.
While interest in the asset is said to be strong, the talks
are progressing slowly, two of the sources said.
The news of renewed interest in Jamieson was reported by the
Wall Street Journal earlier on Monday.

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.